Limflow Inc News Today : Breaking News, Live Updates & Top S

Vascular InterVentional Advances Conference, VIVA23, Clinical Trial Outcomes: PROMISE II (LimFlow) Trial for TADV, PRELUDE Study (LimbSonic) Therapeutic Ultrasound Presented

Published: November 1, 2023

Results from five clinical trials were presented during the VIVA (Vascular InterVentional Advances) Conference, VIVA23, providing outcomes from studies on treatment for chronic limb-threatening ischemia (CLTI), use of drug-coated balloons, among other highly-anticipated late-breaking science findings.

Source: dicardiology.com

First Round of Late-Breaking Clinical Trial Results Announced at VIVA23

Published: October 31, 2023

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

Source: prnewswire.com

LimFlow System's 6-Month Outcomes Presented From the PROMISE II US Pivotal Trial

Published: November 4, 2022

November 4, 2022—Six-month results from the PROMISE II United States pivotal trial of transcatheter arterialization of the deep veins with the L

Source: evtoday.com

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA22

Published: November 2, 2022

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

Source: prnewswire.com

VIVA Foundation Symposium presents Clinical Trial Findings